xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

575

Orlandi et al.

(Continues)

Maxillary antrostomy size is not associated with

post-operative changes in patients’ symptoms of

obstruction, facial pain and rhinorrhea. Less maxillary sinus

At last follow-up (mean 15.6 months), there were no statistically significant differences in clinical

endpoints between patients undergoing Draf2b vs Draf3.

Study Year LOE Study Design Study Groups Clinical Endpoint Conclusions Myller 1976 2011 2 RCT CRSsNP patients in whom: 1. Wide maxillary antrostomy was performed on 1 side (2x natural ostium size) and 2. Uncinectomy alone was Post-operative CT scan findings at 9 months. Post-operative maxillary sinus ostium cross-sectional area. Improvement in overall ipsilateral LM for both surgical treatments. No difference in post-operative overall ipsilateral LM score between surgical treatments. Albu 1978 2004 2 RCT

obstruction in the large antrostomy group compared to the

uncinectomy group at 3

months but not at 6, 9, or 12 months after surgery

change in symptoms

of obstruction, facial

pain and rhinorrhea

Maxillary sinus ostium obstruction at 3, 6, 9, and 12 months.

Patient-reported

SNOT-22

Neo-ostium patency

Surgical revision rate Complications

Surgical CRS patients who underwent:

1. Small maxillary antrostomy (mean diameter 6 mm)

2. Large maxillary antrostomy (mean diameter 16 mm)

Patients with CRS and refractory frontal sinus disease undergoing Draf2b vs Draf3 frontal sinus drillout

performed on the other side

Wadwongtham 1977 2003 2 DBRCT In patients with bilateral and symmetric CRSwNP,

1. Wide maxillary antrostomy was performed on 1 side and 2. Uncinectomy alone was

performed on the other side

(Nonvalidated means of measuring

symptoms and 45% followup)

non-randomized

controlled cohort study

Patel 1991 2018 3 Prospective

TABLE XII-14 (Continued)